Greenwich LifeSciences, Inc. Profile Avatar - Palmy Investing

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which h…

Biotechnology
US, Stafford [HQ]

Income Statements

Loading...
End of GLSI's Analysis
CIK: 1799788 CUSIP: 396879108 ISIN: US3968791083 LEI: - UEI: -
Secondary Listings
GLSI has no secondary listings inside our databases.